Possible online services disruption due to Internet related outage
Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 18, 2013
Drug Name | Review Type | Class | Manufacturer |
---|---|---|---|
Abilify Maintena | New Drug Initial Review | Atypical Antipsychotic | Otsuka America |
Zubsolv | New Drug Initial Review | Narcotic | Orexo |
Tivicay | New Drug Initial Review | HIV antiretroviral | ViiV Healthcare |
Linzess | New Drug Initial Review | Guanylate cyclase-C agonist | Forest |
Tecfidera | New Drug Appeal | Multiple Sclerosis | Biogen Idec |
Avonex | PDL Appeal | Multiple Sclerosis | Biogen Idec |
TrueResult/TrueTrack | PDL Appeal | Diabetes | Nipro Diagnostics |
Dulera | PDL Appeal | Inhaled Corticosteroid | Merck |
Advair Diskus | PDL Appeal | ICS/LABA | GlaxoSmithKline |